Green Future Food Hydrocolloid Marine Science Co., Ltd. (1084) AI Stock Analysis

• Market Cap: HK$542.98M
• Dividend Yield: 1.88%
• Average Volume (3M): 138.20K
• Price to Earnings (P/E): 18.2
• Beta (1Y): 0.25
• Revenue Growth: -10.60%
• EPS Growth: N/A
• Country: HK
• Employees: 1,148
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Agricultural Farm Products
• EPS (TTM): -0.01
• Shares Outstanding: 874,120,000
• 10 Day Avg. Volume: 156,000
• 30 Day Avg. Volume: 138,200
• PEG Ratio: -0.05
• Price to Book (P/B): 0.66
• Price to Sales (P/S): 0.56
• P/FCF Ratio: 8.88
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 59 Neutral
• Price Target: HK$0.66 ▲(6.13% Upside)

The overall stock score is primarily influenced by the company's strong financial recovery, despite challenges in cash flow generation. Technical indicators suggest a bearish trend, while valuation metrics indicate the stock is fairly valued. The absence of earnings call data and corporate events limits additional insights.

Positive Factors

Revenue Recovery

A significant revenue recovery indicates the company's resilience and ability to adapt to market challenges, enhancing its long-term growth prospects.

Improved Margins

Improved margins reflect better cost management and operational efficiency, which can lead to sustainable profitability over the long term.

Balance Sheet Health

A healthier balance sheet with improved debt-to-equity ratio indicates better financial stability and reduced risk, supporting long-term strategic initiatives.

Negative Factors

Cash Flow Challenges

Negative cash flow growth suggests potential liquidity issues, which could limit the company's ability to invest in growth opportunities and manage financial obligations.

Low Cash Conversion

Low cash conversion efficiency indicates that the company may struggle to turn its earnings into cash, impacting its ability to finance operations and growth.

Low Net Profit Margin

A low net profit margin suggests limited profitability, which could hinder the company's ability to reinvest in the business and compete effectively in the market.

Green Future Food Hydrocolloid Marine Science Co., Ltd. Business Overview & Revenue Model

Company Description

Green Future Food Hydrocolloid Marine Science Co., Ltd. is a pioneering company specializing in the production and distribution of hydrocolloids derived from marine resources. Operating within the food technology sector, the company focuses on developing sustainable, natural ingredients that enhance food texture and stability. Their core product line includes various types of seaweed-based hydrocolloids used in food processing, biotechnology, and nutraceutical applications, positioning the company as a leader in eco-friendly and innovative food solutions.

How the Company Makes Money

The company generates revenue primarily through the sale of its hydrocolloid products to food manufacturers, restaurants, and health supplement companies. Key revenue streams include bulk sales of seaweed extracts, customized hydrocolloid formulations, and research and development services for clients seeking tailored solutions. Additionally, Green Future Food has established partnerships with marine research institutions and environmental organizations, which not only enhance their product credibility but also provide access to grants and funding for sustainable practices. The growing demand for natural and plant-based food ingredients further supports the company's profitability.

Green Future Food Hydrocolloid Marine Science Co., Ltd. Financial Statement Overview

Summary

Green Future Food Hydrocolloid Marine Science Co., Ltd. exhibits a mixed financial performance. Improvement in operational efficiency is seen in the income statement, but the balance sheet and cash flow statements indicate financial challenges, with potential liquidity constraints and financial risk due to leverage. Strategic focus on cash management and profitability enhancement is essential for future stability.

Income Statement

The company has faced fluctuating revenue trends, with a recent decline from the prior year. Gross profit margin improved significantly in the latest year, indicating better cost management, but net profit margin is low due to negative net income in previous years. EBIT and EBITDA margins have seen improvement, signaling operational efficiency recovery.

Balance Sheet

The balance sheet shows moderate leverage with a debt-to-equity ratio indicating some financial risk. ROE has been volatile and was negative in recent periods due to net losses. However, the equity ratio shows a healthy portion of the company's assets financed by equity, reflecting stability.

Cash Flow

Cash flow analysis reveals significant challenges. Operating cash flow is inconsistent with recent zero values, and free cash flow has been negative or null, raising concerns about liquidity and financial flexibility. The cash flow from operations has not consistently covered net income, highlighting cash management issues.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	726.43M	1.05B	1.17B	1.64B	1.16B	877.16M
Gross Profit	130.85M	236.71M	41.90M	447.48M	270.43M	190.88M
EBITDA	64.54M	163.93M	-28.75M	390.21M	211.36M	157.09M
Net Income	7.72M	66.15M	-85.33M	199.23M	103.62M	68.90M
Balance Sheet
Total Assets	1.70B	1.67B	1.54B	1.89B	1.70B	1.43B
Cash, Cash Equivalents and Short-Term Investments	89.10M	128.47M	84.10M	43.50M	139.36M	175.38M
Total Debt	603.28M	601.33M	601.97M	649.27M	624.50M	498.94M
Total Liabilities	795.02M	768.39M	789.49M	938.99M	837.68M	674.66M
Stockholders Equity	898.69M	893.68M	745.24M	945.20M	841.98M	746.25M
Cash Flow
Free Cash Flow	28.51M	66.83M	84.75M	-82.78M	-16.41M	-49.42M
Operating Cash Flow	60.21M	116.95M	96.52M	-32.19M	61.11M	11.64M
Investing Cash Flow	-32.38M	-46.59M	-8.13M	-51.60M	-137.17M	-57.65M
Financing Cash Flow	-41.04M	-39.93M	-20.55M	-5.01M	99.46M	44.04M

Green Future Food Hydrocolloid Marine Science Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.62
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1084, the sentiment is Positive. The current price of 0.62 is below the 20-day moving average (MA) of 0.63, below the 50-day MA of 0.64, and below the 200-day MA of 0.68, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 53.96 is Neutral, neither overbought nor oversold. The STOCH value of 61.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1084.

Green Future Food Hydrocolloid Marine Science Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1936	67 Neutral	HK$335.12M	20.41	5.90%	―	14.31%	-8.40%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
1084	59 Neutral	HK$542.98M	18.23	3.41%	1.88%	-10.60%	―
0197	51 Neutral	HK$54.39M	-0.23	-30.07%	―	-3.16%	33.72%
0682	48 Neutral	HK$54.38M	-3.18	-7.84%	―	-15.08%	12.98%
6911	45 Neutral	HK$141.52M	-0.87	-42.06%	10.64%	-41.81%	-645.06%

Green Future Food Hydrocolloid Marine Science Co., Ltd. Corporate Events

Green Fresh Biotechnology Reports Financial Decline in 1H2025

Green Fresh Biotechnology Company Limited reported a decline in financial performance for the first half of 2025, with revenue decreasing by 10.7% to RMB410.0 million compared to the same period in 2024. The company experienced a net loss of RMB12.3 million, a significant drop from a net profit of RMB22.6 million in the previous year, leading to a decision not to distribute interim dividends. This downturn reflects challenges in maintaining profit margins and managing costs, impacting its market positioning and shareholder returns.

Green Fresh Biotechnology Schedules Board Meeting for Interim Results

Green Fresh Biotechnology Company Limited has announced that its board of directors will hold a meeting on August 28, 2025, to approve the interim results for the first half of the year and consider the recommendation of an interim dividend. This announcement indicates the company’s ongoing commitment to transparency and shareholder engagement, potentially impacting investor confidence and market positioning.

Green Fresh Biotechnology Issues Profit Warning for H1 2025

Green Fresh Biotechnology Company Limited has issued a profit warning for the first half of 2025, anticipating a net loss of approximately RMB11.0 million to RMB13.5 million, compared to a net profit of RMB23.08 million in the same period of 2024. The decline in performance is attributed to reduced selling prices and sales quantities of major products, alongside increased research and development expenses. The company is finalizing its interim results, which are expected to be published by the end of August 2025.